Plymouth Meeting based Geneos Therapeutics is developing DNA-based personalized therapeutic cancer vaccines
Houston/Philadelphia based ImmunoGenesis is trying to turn cold tumors hot with a PD‑L1/PD‑L2 dual‑specific inhibitor
Pittsburgh based Neuro-Innovators is developing three drugs to improve neuroplasticity to enhance the effectiveness of rehab post-stroke
The CEO of Life Sciences PA introduces us to the Life Sciences Future meeting and shares his take on the health of the sector
With expertise in delivering drugs to the liver, Medivir recently had data at ESMO for its lead liver cancer drug, fostrox
Vicore Pharma's CEO describes the rationale for using angiotensin II type 2 receptor agonists in IPF
Basilea, a profitable anti-infectives company, today landed a contract with BARDA worth up to $268M to develop antifungals and antibiotics
BioInvent's CEO highlights TNFR2 data recently presented at ESMO, and more in the company's pipeline
Pareto Securities' biotech analyst Dan Akschuti gives an overview of the 15th Annual Healthcare Conference and highlights companies in the region
The co-founder of Stockholm's Stratipath talks digital pathology and what it was like to spin out of the prestigious Karolinska Institute
Oxford BioTherapeutics' OGAP platform, a cancer specific membrane protein library, has enabled the company to find cancer targets for its own pipeline and partners alike
Oxford Science Park based Nucleome is harnessing its ability to read the "dark genome" to develop therapies for inflammatory disease and beyond
Biotech industry veteran Pascal Besman shares advice for European companies on how to best present yourself to U.S. investors
Oxford Science Park based Sitryx aims to be a leader immunometabolism - a deal with Lilly has been validating
Since 1986, Madrid's PharmaMar has been searching the world's oceans for new cancer medicines - it has already led to three approved drugs
Getting a general overview of protein splicing at Barcelona's SpliceBio
From Biocom California's Women's Health Conference: The Co-Founder and CEO of AccendoWave describes the importance of understanding women's pain data
William Blair analyst Matt Phipps reviews key #ESMO24 data from his coverage list
From Biocom California Women's Health Conference: Crescent Ridge Managing Partner Maria Gonzalez-Blanch talks about investing in women's health
Veracyte's CEO talks about ESMO data from its prostate cancer diagnostic that could change how metastatic prostate cancer is treated
.png){kind=logo}
